Sol-Gel Technologies Ltd. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
SLGL Nasdaq 2830 www.sol-gel.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sol-Gel Technologies Ltd.

New Strong Buy Stocks for October 16th - Oct 16th, 2026 1:04 am
Sol-Gel Eyes 2028 Launch as SGT-610 Nears Pivotal Gorlin Syndrome Data - Oct 14th, 2026 9:02 pm
SolGel Technologies (SLGL) Upgraded to Buy: Here's Why - Oct 8th, 2026 9:00 am
Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026 - Sep 30th, 2026 7:14 am
SolGel Technologies (SLGL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Sep 17th, 2026 7:55 am
Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome - Sep 17th, 2026 6:30 am
Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - Aug 20th, 2026 6:30 am
Metagenomi Therapeutics (MGX) Reports Q2 Loss, Lags Revenue Estimates - Aug 10th, 2026 3:55 pm
Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates - Jul 29th, 2026 6:35 pm
Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates - May 28th, 2026 6:00 am
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering - Mar 23rd, 2026 7:38 pm
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates - Mar 19th, 2026 12:00 pm
Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025 - Mar 19th, 2026 6:53 am
Sol-Gel Technologies (NASDAQ:SLGL) shareholders have earned a 940% return over the last year - Feb 11th, 2026 11:23 am